- Home
- FCBC vs RLAY Comparison
FCBC vs RLAY Comparison
Compare FCBC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCBC
- RLAY
- Stock Information
- Founded
- FCBC 1874
- RLAY 2015
- Country
- FCBC United States
- RLAY United States
- Employees
- FCBC N/A
- RLAY N/A
- Industry
- FCBC Major Banks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCBC Finance
- RLAY Health Care
- Exchange
- FCBC Nasdaq
- RLAY Nasdaq
- Market Cap
- FCBC 696.3M
- RLAY 803.4M
- IPO Year
- FCBC 1992
- RLAY 2020
- Fundamental
- Price
- FCBC $34.15
- RLAY $5.48
- Analyst Decision
- FCBC
- RLAY Strong Buy
- Analyst Count
- FCBC 0
- RLAY 8
- Target Price
- FCBC N/A
- RLAY $17.25
- AVG Volume (30 Days)
- FCBC 44.4K
- RLAY 1.6M
- Earning Date
- FCBC 10-21-2025
- RLAY 11-05-2025
- Dividend Yield
- FCBC 3.63%
- RLAY N/A
- EPS Growth
- FCBC N/A
- RLAY N/A
- EPS
- FCBC 2.72
- RLAY N/A
- Revenue
- FCBC $162,762,000.00
- RLAY $8,355,000.00
- Revenue This Year
- FCBC $2.27
- RLAY $27.33
- Revenue Next Year
- FCBC $11.13
- RLAY $8.87
- P/E Ratio
- FCBC $12.54
- RLAY N/A
- Revenue Growth
- FCBC N/A
- RLAY N/A
- 52 Week Low
- FCBC $32.81
- RLAY $1.78
- 52 Week High
- FCBC $49.02
- RLAY $7.07
- Technical
- Relative Strength Index (RSI)
- FCBC 31.48
- RLAY 75.63
- Support Level
- FCBC $33.88
- RLAY $5.17
- Resistance Level
- FCBC $34.86
- RLAY $5.42
- Average True Range (ATR)
- FCBC 0.92
- RLAY 0.29
- MACD
- FCBC -0.25
- RLAY 0.08
- Stochastic Oscillator
- FCBC 6.55
- RLAY 95.97
About FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).